Literature DB >> 23081800

TNF-α has tropic rather than apoptotic activity in human hematopoietic progenitors: involvement of TNF receptor-1 and caspase-8.

Keren Mizrahi1, Jerry Stein, Isaac Yaniv, Offer Kaplan, Nadir Askenasy.   

Abstract

Tumor necrosis factor-α (TNF-α) has been suggested to exert detrimental effects on hematopoietic progenitor function that might limit the success of transplants. In this study, we assessed the influences of TNF-α and its two cognate receptors on the function of fresh umbilical cord blood (UCB) and cryopreserved mobilized peripheral blood (mPB). CD34(+) progenitors from both sources are less susceptible to spontaneous apoptosis than lineage-committed cells and are not induced into apoptosis by TNF-α. Consequently, the activity of UCB-derived severe combined immune deficiency (SCID) reconstituting cells and long-term culture-initiating cells is unaffected by this cytokine. On the contrary, transient exposure of cells from both sources to TNF-α stimulates the activity of myeloid progenitors, which persists in vivo in UCB cell transplants. Progenitor stimulation is selectively mediated by TNF-R1 and involves activation of caspase-8, without redundant activity of TNF-R2. Despite significant differences between fresh UCB cells and cryopreserved mPB cells in susceptibility to apoptosis and time to activation, TNF-α is primarily involved in tropic signaling in hematopoietic progenitors from both sources. Cytokine-mediated tropism cautions against TNF-α neutralization under conditions of stress hematopoiesis and may be particularly beneficial in overcoming the limitations of UCB cell transplants.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23081800     DOI: 10.1002/stem.1259

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  8 in total

1.  Activation and crosstalk between TNF family receptors in umbilical cord blood cells is not responsible for loss of engraftment capacity following culture.

Authors:  Keren Mizrahi; Nadir Askenasy
Journal:  Am J Stem Cells       Date:  2013-12-22

Review 2.  TNF-α, a good or bad factor in hematological diseases?

Authors:  Tian Tian; Min Wang; Daoxin Ma
Journal:  Stem Cell Investig       Date:  2014-06-01

3.  Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts.

Authors:  K Mizrahi; I Yaniv; S Ash; J Stein; N Askenasy
Journal:  Bone Marrow Transplant       Date:  2014-02-24       Impact factor: 5.483

4.  TNF-α-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanoma.

Authors:  Mohammad N Uddin; Yubin Zhang; Jonathan A Harton; Katherine C MacNamara; Dorina Avram
Journal:  J Immunol       Date:  2014-01-20       Impact factor: 5.422

5.  Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts.

Authors:  K Mizrahi; S Ash; T Peled; I Yaniv; J Stein; N Askenasy
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

Review 6.  Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis.

Authors:  Shai Yarkoni; Jerry Stein; Isaac Yaniv; Nadir Askenasy
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

7.  Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34+ Cells.

Authors:  Dorian Forte; Daria Sollazzo; Martina Barone; Marisole Allegri; Angela di Martella Orsi; Marco Romano; Barbara Sinigaglia; Giuseppe Auteri; Nicola Vianelli; Michele Cavo; Francesca Palandri; Lucia Catani
Journal:  Mediators Inflamm       Date:  2018-07-04       Impact factor: 4.711

8.  Integrated Metabolomics and Network Pharmacology Approach to Explain Possible Action Mechanisms of Xin-Sheng-Hua Granule for Treating Anemia.

Authors:  Han-Qing Pang; Shi-Jun Yue; Yu-Ping Tang; Yan-Yan Chen; Ya-Jie Tan; Yu-Jie Cao; Xu-Qin Shi; Gui-Sheng Zhou; An Kang; Sheng-Liang Huang; Ya-Jun Shi; Jing Sun; Zhi-Shu Tang; Jin-Ao Duan
Journal:  Front Pharmacol       Date:  2018-03-02       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.